 | 2022 | Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real‑world observational study | Alcalá, Carmen; Quintanilla-Bordás, Carlos; Gascón, Francisco; Perez-Sempere, Angel; Navarro, Laura; Carcelén‑Gadea, María; Landete, Lamberto; Mallada, Javier; Cañizares, Emmanuel; Belenguer, Antonio; Carratalá, Sara; Domínguez, José Andrés; Pérez‑Miralles, Francisco Carlos; Gil‑Perotín, Sara; Gasqué, Raquel; Cubas, Laura; Castillo, Jéssica; Casanova, Bonaventura |  |
 | 2021 | Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population | Fernandez-Diaz, Eva; Perez-Vicente, Jose A.; VILLAVERDE GONZALEZ, RAMON; Berenguer Ruiz, Leticia; Candeliere Merlicco, Antonio; Martinez-Navarro, Maria Luisa; Gracia Gil, Julia; Romero-Sanchez, Carlos M.; Alfaro Sáez, Arantxa; Diaz, Inmaculada; Gimenez‑Martinez, Juana; Mendez-Miralles, Maria Angeles; Millan-Pascual, Jorge; Jimenez-Pancho, Javier; Mola, Santiago; Sempere, Angel P. |  |
.png){kind=logo}